Search Results - Zhuleku, E.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    P40 REAL‐WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD‐LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE

    P40 REAL‐WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD‐LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE by Lehne, M., Kortüm, K.M., Zamagni, E., d'Estrube, T., Shukla, S., Zhuleku, E., Ghiani, M., Hanna, M., Maywald, U., Wilke, T., Perera, S.

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    RWD37 Pre-/Post Prevalence of Cardiovascular Diseases in Hospitalized COVID Patients: A German Claims Data Analysis

    RWD37 Pre-/Post Prevalence of Cardiovascular Diseases in Hospitalized COVID Patients: A German Claims Data Analysis by Appiah, K., Mevius, A., Fuchs, A., Müller, S., Zhuleku, E.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    RWD58 Coding of Multiple Sclerosis Subtypes in German Administrative Claims Data: A Validation Study Using the MSDS-AOK PLUS Linked Database

    RWD58 Coding of Multiple Sclerosis Subtypes in German Administrative Claims Data: A Validation Study Using the MSDS-AOK PLUS Linked Database by Zhuleku, E, Ziemssen, T, Dillenseger, A, Maywald, U, Wilke, T, Ghiani, M

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    RWD126 Introducing the German MSDS-AOK PLUS Database: Linkage of Administrative Claims Data and a Patient Registry for Advanced RWE Capabilities in Multiple Sclerosis

    RWD126 Introducing the German MSDS-AOK PLUS Database: Linkage of Administrative Claims Data and a Patient Registry for Advanced RWE Capabilities in Multiple Sclerosis by Zhuleku, E, Ziemssen, T, Dillenseger, A, Maywald, U, Wilke, T, Ghiani, M

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    RWD113 Switching to TNFi Versus Non-TNFi Biologics in Ulcerative Colitis Patients: Real-World Outcomes from a German Claims Data Analysis

    RWD113 Switching to TNFi Versus Non-TNFi Biologics in Ulcerative Colitis Patients: Real-World Outcomes from a German Claims Data Analysis by Zhuleku, E., Wirth, D., Nissinen, R., Passey, A., Bravatà, I., Ziavra, D., Duva, A., Lee, J., Maywald, U., Wilke, T., Bokemeyer, B.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: